Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Meningeal Carcinomatosis 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1

Interventions

Cyclophosphamide 10fludarabine phosphate 9Peripheral Blood Stem Cell Transplantation 8Cyclosporine 8Mycophenolic Acid 6Busulfan 6Filgrastim 5Antilymphocyte Serum 5Radiotherapy 4Psychiatric Rehabilitation 4Methotrexate 4fludarabine 3Whole-Body Irradiation 3Tacrolimus 3Melphalan 3Flow Cytometry 3Cord Blood Stem Cell Transplantation 3Aprepitant 3thymoglobulin 2Therapeutics 2Ondansetron 2Methylprednisolone 2Dexamethasone 2Calcium Dobesilate 2Analgesia 2sargramostim 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1Voriconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Primary Myelofibrosis × merphos × Clear all
NCT00445744 2018-01-02

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase NA Completed
52 enrolled 7 charts
MyeloidOther hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡